Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer.
Zirakzadeh AA, Kinn J, Krantz D, Rosenblatt R, Winerdal ME, Hu J, Hartana CA, Lundgren C, Bergman EA, Johansson M, Holmström B, Hansson J, Sidikii A, Vasko J, Marits P, Sherif A, Winqvist O.
Zirakzadeh AA, et al. Among authors: winerdal me.
Clin Immunol. 2017 Mar;176:63-70. doi: 10.1016/j.clim.2016.12.003. Epub 2016 Dec 24.
Clin Immunol. 2017.
PMID: 28025135